Selective Blockade of Vascular Endothelial Growth Factor Receptor 2 With an Antibody Against Tumor-Derived Vascular Endothelial Growth Factor Controls the Growth of Human Pancreatic Adenocarcinoma Xenografts

Author: Holloway Shane   Beck Adam   Shivakumar Latha   Shih Jessica   Fleming Jason   Brekken Rolf  

Publisher: Springer Publishing Company

ISSN: 1068-9265

Source: Annals of Surgical Oncology, Vol.13, Iss.8, 2006-08, pp. : 1145-1155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content